Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
How do you manage HPV positive squamous cell carcinoma in situ of the oropharynx?
Answer from: Radiation Oncologist at Academic Institution
transoral surgery
Sign In
or
Register
to read more
3210
Related Questions
How would you approach post-op radiation recommendations in patients who had neoadjuvant chemoimmunotherapy for HPV mediated OPSCC s/p TORS who have a complete pathologic response (pCR)?
How would you manage a presumed radiation induced sarcoma of the head and neck?
What is the recommended treatment approach for stage III/IVA nasopharyngeal cancer that is p16 negative and EBV positive?
For a patient s/p TORS with indications for adjuvant radiation, how does your management change with persistently elevated ctHPVDNA?
What is the role for chemo immunotherapy in the up front setting in non-metastatic head & neck cancer outside of clinical trials?
What are your top takeaways in Head & Neck Cancers from ASCO 2025?
What is the role of radiation therapy for Kimura's disease of the parotid and neck?
How would the updated results of ECOG 3311 influence your adjuvant RT recommendations for HPV+ OPSCC?
Would you recommend adjuvant radiation for a patient with head/neck merkel cell carcinoma following a pathologic complete response to neoadjuvant immunotherapy?
What dose would you use for a plaque brachytherapy for a melanoma involving the iris?